Angiotensin II-receptor blockers: Will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?

Norman M Kaplan

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

In the past few years, angiotensin II-receptor blockers have become available and are being heavily marketed and increasingly used. In various ways they differ from angiotensin-converting enzyme inhibitors (ACEIs). Until outcome data are available, they should continue to be used primarily in patients who should receive an ACEI but cannot tolerate the drug because of cough.

Original languageEnglish (US)
Pages (from-to)S87-S90
JournalJournal of Human Hypertension
Volume14
DOIs
StatePublished - Apr 2000

Keywords

  • Angiotensin II
  • Angiotensin II-receptor blockers
  • Angiotensin-converting enzyme inhibitors

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Angiotensin II-receptor blockers: Will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?'. Together they form a unique fingerprint.

Cite this